Wednesday, May 14, 2025
Wednesday, May 14, 2025

A research team has successfully developed a novel pneumococcal vaccine by combining the team's proprietary mucosal vaccine technology with pneumococcal surface proteins that can cover a wide range of serotypes. Experiments were conducted using mice and macaques and it was confirmed that pneumonia caused by pneumococcal infection was clearly suppressed in the target groups of animals inoculated with the vaccine.
Read more …Macaque trials offer hope in pneumonia vaccine development

More Articles …

  1. At least 20,000 annual UK cancer deaths avoidable, says charity
  2. Spike in premature births caused by COVID, halted by vaccines, study finds
  3. Kids who feel their parents are less reliable take fewer risks vital to learning and growth
  4. Discrimination during pregnancy can affect infant's brain circuitry
  5. Child care centers aren't a likely source of COVID-19 spread, study says
  6. Parents 'destroyed' after baby's death at Royal Sussex County Hospital
Page 1308 of 1534